Bridgebio Pharma Inc (BBIO-Q) Profile - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Bridgebio Pharma Inc

3160 PORTER DR. SUITE 250
PALO ALTO CA 94304 USA
P: 650-391-9740
http://www.bridgebio.com

Sectors & Indices

Sector

Industry

Employees

Profile

BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.

Key Executives

Name	Title
Neil Kumar	CEO/CEO, Subsidiary/Director/Founder/President/President, Subsidiary
Brian C. Stephenson	CFO/Chief Accounting Officer/Secretary

More from The Globe

investor newsletter

A look at how people are using the best all-around investing product. Plus, top stock picks from our new Readers’ Portfolio

The close: Month-end repositioning spurs late-day stock rally

Why this money manager thinks investors should get off the sidelines but still be defensive

globe advisor weekly newsletter

Canadian investors are ‘underserved’ in alternative investments and private capital

November 25, 2022

Why rising interest in traditional fixed income is not affecting alternatives

September 20, 2022

Fund houses buy up ‘alts’ specialists to move beyond equities and bonds

Four reasons why wealthy investors should hold farmland in their portfolios

Four ways to create more diversified and resilient portfolios